KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 46 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $25,000 | -3.8% | 53,635 | 0.0% | 0.00% | – |
| Q1 2015 | $26,000 | -78.7% | 53,635 | -24.1% | 0.00% | – |
| Q4 2014 | $122,000 | -5.4% | 70,635 | -15.5% | 0.00% | – |
| Q3 2014 | $129,000 | -24.1% | 83,635 | +12.1% | 0.00% | – |
| Q2 2014 | $170,000 | -14.6% | 74,635 | +1.4% | 0.00% | – |
| Q1 2014 | $199,000 | -10.0% | 73,635 | +47.3% | 0.00% | – |
| Q4 2013 | $221,000 | -45.0% | 50,000 | -43.8% | 0.00% | -100.0% |
| Q3 2013 | $402,000 | +197.8% | 89,000 | +270.8% | 0.00% | – |
| Q2 2013 | $135,000 | – | 24,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,632,928 | $11,901,000 | 3.36% |
| DAFNA Capital Management LLC | 250,000 | $1,130,000 | 1.23% |
| WALL STREET ASSOCIATES | 625,200 | $2,826,000 | 0.26% |
| Lehman Brothers Holdings Inc. | 942,092 | $4,258,000 | 0.20% |
| Old West Investment Management, LLC | 54,517 | $246,000 | 0.12% |
| WEXFORD CAPITAL LP | 278,460 | $1,259,000 | 0.10% |
| CLOUGH CAPITAL PARTNERS L P | 400,000 | $1,808,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 105,408 | $476,000 | 0.03% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,706,675 | $21,274,000 | 0.03% |
| TUDOR INVESTMENT CORP ET AL | 125,000 | $565,000 | 0.02% |